Enova International, Inc. logo ENVA - Enova International, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 7
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $240.00 DETAILS
HIGH: $280.00
LOW: $200.00
MEDIAN: $240.00
CONSENSUS: $240.00
UPSIDE: 0.63%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Banks, Insurers & Asset Managers 80% confidence

Primary model: P/Tangible Book × ROE Quality

Valuation Signal Overvalued Moderate
Trading 32.6% above fair value
Current Price $238.50
Bear Case $125.95 47.2% downside ($125.95 - $238.50) / $238.50 = -47.2% ROTCE 20.0% → 2.29x TBV
Fair Value $179.93 24.6% downside ($179.93 - $238.50) / $238.50 = -24.6% ROTCE 25.0% → 3.62x TBV
Bull Case $233.91 1.9% downside ($233.91 - $238.50) / $238.50 = -1.9% ROTCE 30.0% → 3.72x TBV

Adjust Assumptions

29.3%
11.0%

Key Value Driver

ROTCE (29.3%) vs. cost of equity (11.0%)

Implied Market Multiple 5.63x

Plain-Language Summary

Our base-case estimate uses P/Tangible Book × ROE Quality. We then blend that result with the average analyst price target of $240.00 from 10 analysts, using a 20% weight on analyst consensus. That produces an estimated intrinsic value of $179.93 per share.

Warnings

Traditional cash flow models don't work well for banks — lending activity distorts how much cash the business actually generates.
Common valuation shortcuts don't apply here — for banks, interest payments are a core business cost, not overhead.
Wall Street's average price target is $240.00 (from 10 analysts). Our estimate is 31% below the consensus -- consider that gap carefully.

Key Risks

  • Book value quality matters as much as level — check loan loss reserves
  • Interest rate sensitivity creates non-linear earnings surprises
  • Insurance reserving is actuarial, not financial — errors emerge slowly